KELLEY JENKINS: Open Payments
NPI 1275896326 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,772 in 99 payments from 23 companies in 2025. Trend: 2023 $819 · 2024 $1,437 · 2025 $1,772
Food & beverage: $1,772
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 14 | $275 |
| Dexcom, Inc. | 18 | $184 |
| Novo Nordisk Inc | 10 | $181 |
| Globus Medical, Inc. | 4 | $149 |
| Amgen Inc. | 13 | $145 |
| Insulet Corporation | 5 | $122 |
| Radius Health, Inc. | 4 | $104 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $80 |
| Novartis Pharmaceuticals Corporation | 4 | $67 |
| Chiesi USA, Inc. | 3 | $66 |
Products named: FREESTYLE LIBRE, Dexcom G6 Transmitter, Senza, Omnipod, Ozempic, Tymlos, ISTURISA, MYCAPSSA.
Industry payments across MO — which companies pay providers there.
